BaltaIBaltaSDemirkolS. Aortic arterial stiffness is a moderate predictor of cardiovascular disease in patients with psoriasis vulgaris[Published online May 1, 2013]. Angiology. 2013. doi: 10.1177/0003319713485805
2.
AltunBBulucuFDemirbasS. The relationship between some of the cardiovascular risk factors and arterial stiffness parameters in essentially hypertensive patients[published online November 29, 2012]. Clin Exp Hypertens. 2012.
3.
AchimastosADEfstathiouSPChristoforatosTPanagiotouTNStergiouGSMountokalakisTD. Arterial stiffness: determinants and relationship to the metabolic syndrome. Angiology. 2007;58(1):11–20.
4.
ZhuCXiongZZhengZChenYQianXChenX. Association of serum gamma-glutamyltransferase with arterial stiffness in established coronary artery disease. Angiology. 2013;64(1):15–20.
5.
TiculescuCRVrizOSparacinoL. Incremental value of arterial stiffness over traditional risk factors in predicting subclinical cardiovascular remodeling in patients with moderate chronic renal failure. Angiology. 2011;62(8):662–668.
6.
VyssoulisGPKarpanouEAKyvelouSM. Beneficial effect of angiotensin II type 1 receptor blocker antihypertensive treatment on arterial stiffness: the role of smoking. J Clin Hypertens (Greenwich). 2008;10(3):201–207.
7.
FengSQYePLuoLM. Associations of plasma homocysteine and high-sensitivity C-reactive protein levels with arterial stiffness in Chinese population: a community-based study. Chin Med J. 2012;125(1):44–49.
8.
KarabudakOUlusoyREErikciAASolmazgulEDoganBHarmanyeriY. Inflammation and hypercoagulable state in adult psoriatic men. Acta Derm Venereol. 2008;88(4):337–340.
9.
HaniAFPrakasaENugrohoHAffandiAMHusseinSH. Body surface area measurement and soft clustering for PASI area assessment. Conf Proc IEEE Eng Med Biol Soc. 2012;2012:4398–4401.
10.
AhlehoffOSkovLGislasonG. Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort study. J Intern Med. 2013;273(2):197–204.
